000710
vs
S
Shanghai Composite
000710
Over the past 12 months, Berry Genomics Co Ltd has underperformed Shanghai Composite, delivering a return of -14% compared to the Shanghai Composite's +24% growth.
Stocks Performance
000710 vs Shanghai Composite
Performance Gap
000710 vs Shanghai Composite
Performance By Year
000710 vs Shanghai Composite
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Berry Genomics Co Ltd
Glance View
Berry Genomics Co., Ltd. engages in the gene detection and sales of equipment and reagents of high-throughput sequencing technology. The company is headquartered in Beijing, Beijing and currently employs 1,490 full-time employees. The firm's business is comprised of basic scientific research services, medical testing services, testing reagent sales and testing equipment sales. The basic scientific research services business provides the clients with multiple sequencing platforms for testing projects, such as transcriptome sequencing, human whole exome sequencing and whole genome sequencing. The medical testing services business include tumor genetic testing services, genetic disease genetic testing services and reproductive health testing services. The firm sells a range of reagents and equipment, including NextSeq CN500 gene sequencer and general reagents for sequencing reactions.
